MustGrow's Canola Field Trials Demonstrate Clubroot Disease Suppression; Improved Canola Yield with Healthier Root Systems

Executive Summary

• MustGrow Biologics announced completion of a two‑year, ~100‑acre field trial program in the Canadian Prairies demonstrating that its mustard‑derived biocontrol product TerraMG™ significantly suppresses clubroot disease in canola.
• In the wetter 2024 season, treated plots showed up to 95 % reduction in resting clubroot spores and delivered a yield increase of 7 bushels/acre (≈19 %), equating to roughly $91/acre of added value.
• In the drier 2025 season, TerraMG™ still outperformed controls with a modest 1‑2 bushel/acre yield lift despite lower disease pressure.

Key Details

• Trial Scope: Approximately 100 acres across multiple sites in Saskatchewan and other Prairie provinces; conducted by MustGrow’s wholly‑owned Canadian marketing/distribution arm, NexusBioAg, over the 2024–2025 growing seasons.
• Disease Suppression:
• 2024: Up to 95 % reduction in clubroot (P. brassicae) resting spore concentrations versus untreated plots.
• Visual root‑gall assessments confirmed markedly lower severity and incidence on treated fields.
• Yield Impact:
• 2024: +7 bushels/acre average increase (19 % above the Canadian 2024 average of 36 bushels/acre).
• Economic benefit estimated at ≈$91 per acre (based on $13/bushel commodity price).
• 2025: +1‑2 bushels/acre increase, reflecting reduced disease pressure in a drier season.
• Mechanism of Action: TerraMG™ releases naturally occurring isothiocyanates from mustard seed meal, providing fungicidal and biocidal activity against soil‑borne pathogens, including clubroot.
• Regulatory Status: MustGrow is actively pursuing registration of TerraMG™ with Health Canada’s Pest Management Regulatory Agency.
• Market Context: Canadian canola production valued at ~$14 billion in 2025 (≈21.8 million tonnes @ $650/tonne). No effective registered products currently exist for clubroot suppression, creating a significant market opportunity.
• Future Outlook: Successful trial results support further commercialization efforts and potential expansion of TerraMG™ to other soil‑borne disease challenges.

Notable Quotes

“Field trial findings have demonstrated MustGrow's TerraMG™ is a sustainable technology capable of suppressing clubroot parasitic disease and promoting higher canola yields and root systems under various disease pressures.” – Corey Giasson, Director & CEO, MustGrow Biologics Corp.